On September 8, Stella Mental Health announced its acquisition of Bespoke Treatment, a Joint Commission accredited integrative mental health facility based in Los Angeles, California.
Founded in 2019 by neuroscientist Ben Spielberg, Bespoke Treatment has become known for its comprehensive and personalized approach to mental health care, offering both traditional psychiatric services and advanced interventional treatments. Bespoke Treatment provides a full spectrum of services, ranging from general psychiatry and psychotherapy to personalized transcranial magnetic stimulation, Spravato®, IV ketamine and intensive outpatient programming.
Stella Mental Health is an interventional psychiatry practice dedicated to delivering effective mental health protocols for severe trauma, stress, anxiety, depression and post-traumatic stress injury. It is based in New York City and has multiple locations across the country.
With this acquisition, Stella Mental Health will add the Dual Sympathetic Reset Stellate Ganglion Block, a treatment for trauma-related symptoms, to the list of therapies available to patients in Los Angeles and Santa Monica. Financial terms of the deal were not disclosed.
According to data captured in the LevinPro HC database, this transaction represents the 67th Behavioral Health Care (BHC) acquisition of 2025, and the second in the transcranial magnetic stimulation provider specialty. There were four transcranial magnetic stimulation provider deals announced during 2024, and none announced during 2023.
